Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumonia

COVACTA trial did not meet its primary endpoint of improved clinical status in patients with COVID-19 associated pneumonia, or the key secondary endpoint of reduced patient mortality The study is the first global, randomised, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting Roche remains committed to continuing the Actemra/RoActemra clinical trial programme in... Read more

Zymo Research Releases Free Software to Streamline COVID-19 Test Reporting

CALIFORNIA LABORATORIES CAN NOW INSTANTLY TRANSMIT COVID-19 DATA TO THE CALREDIE SYSTEM IRVINE, Calif., (July 28, 2020) — Zymo Research recently has released a free open-source software program that allows California laboratories to rapidly report COVID-19 test data to the California Reportable Disease Information Exchange (CalREDIE). According to the California Department of Public Health (CDPH) website,... Read more

PerkinElmer Launches Online, Open Access COVID-19 Data Dashboards to Accelerate Antiviral Therapeutics Research

Informatics Tools Help Scientists Access, Aggregate and Analyze Drug Compound and Clinical Trial Data WALTHAM, Mass. — July 22, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has launched two online, free-access Perkin Elmer COVID-19 Data Dashboards to help the global scientific community accelerate the... Read more

Bio-Techne Announces Launch of Exocovid-19 Test for Detection of SARS-CoV-2 in Patient Samples

MINNEAPOLIS, July 21, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed validation testing for COVID-19 caused by the novel coronavirus (SARS-CoV-2) and now offers the ExoCovid-19 test for detection of the virus in patient samples. The ExoCovid-19 test will be performed in its CLIA-certified, CAP-accredited laboratory. Exosome Diagnostics, the... Read more

Thermo Fisher Scientific's Response to COVID-19 Continues to Expand to Support Development and Production of Therapeutics and Vaccines

Thermo Fisher Scientific’s Response to COVID-19 Continues to Expand to Support Development and Production of Therapeutics and Vaccines Leading pharma services network brings unmatched scalability, flexibility and expertise to support the global response WALTHAM, Mass., July 20, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, continues to expand global... Read more

Thermo Fisher Scientific's Response to COVID-19 Continues to Expand to Support Development and Production of Therapeutics and Vaccines

Leading pharma services network brings unmatched scalability, flexibility and expertise to support the global response WALTHAM, Mass., July 20, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as... Read more

Promega Maxwell® RNA Extraction System Authorized for Use in CDC COVID-19 Emergency Use Authorization (EUA) Diagnostic Panel

Promega automated sample preparation solution added to CDC COVID-19 test protocol Madison, WI USA. (July 16, 2020) Promega Corporation Maxwell® RSC 48 Instrument and Maxwell® RSC Viral Total Nucleic Acid Purification Kit (Maxwell® Extraction System) are now in the Centers for Disease Control and Prevention’s (CDC) COVID-19 diagnostic protocol for emergency use. In a letter dated July... Read more

Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia

Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia CARLSBAD, Calif., July 13, 2020 /PRNewswire/ — Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next-generation sequencing... Read more

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan CARLSBAD, Calif., July 8, 2020 /PRNewswire/ — Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical Co., Ltd., a member of the Roche Group, and has applied... Read more